Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
29%(2 trials)

Phase Distribution

Ph phase_4
3
27%
Ph not_applicable
7
64%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(7)
Terminated(1)
Other(3)

Detailed Status

Completed7
unknown3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (30.0%)
N/A7 (70.0%)

Trials by Status

withdrawn19%
unknown327%
completed764%

Recent Activity

Clinical Trials (11)

Showing 11 of 11 trials

All 11 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11